Why Neil Woodford Is Backing Technology

Neil Woodford will be shopping for companies like Tissue Regenix Group PLC (LON:TRX), Imperial Innovations Group plc (LON:IVO) and IP Group Plc (LON:IPO) for his new fund.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Star fund manager Neil Woodford is renowned for ploughing his own furrow. Going against the crowd enabled him, during his tenure of the Invesco Perpetual High Income Fund, to turn a £10,000 investment in 1988 into over £230,000 (with income reinvested) by the time he departed.

The master investor’s new venture, the CF Woodford Equity Income Fund, which launches on 2 June, will be managed very much along the same lines. And that means up to 7% of the fund will be in small, early-stage businesses.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Run-of-the-mill fund managers would consider such investments risky. But Woodford claims he’s had only one disaster in this area in the last 10 years and “many, many” successes.

ThumbUp1

Brit tech champion

Woodford has a passion for British science. He was quoted in the Guardian as saying:

“No other country matches Britain in its track record of scientific discovery … We do science and innovation incredibly well, but we have a lamentable record in converting top science into top businesses”.

Woodford’s interest in supporting start-up businesses coming out of British universities and research centres isn’t driven by a sentimental patriotism. Rather, he sees himself as being presented with incredible opportunities”, due to under-funding in the area.

Speaking to What Investment earlier this month, Woodford said:

“While changing [under-funding] is socially useful, I do want a return. I am not in this for totally altruistic reasons. The demand for capital is high, but the supply of capital is very low, and you don’t need more than an O-Level in economics to understand that in those circumstances there is a lot of value to be had for investors”.

3 companies that fit the bill

Tissue Regenix Group (LSE: TRX) was formed in 2006 when it was spun-out from the University of Leeds. The group’s patented regenerative technology enables animal and human tissue to be used to repair diseased or worn out body parts in areas such as vascular disease, heart valve replacement and knee repair.

The AIM-listed group made an operating loss of £6.6m last year, but still has a cash pile of £18.5m to accelerate its commercial roll-out programme.

Imperial Innovations Group (LSE: IVO) was founded in 1986 and listed on AIM in 2006. Imperial is an investment company that provides capital and other assistance for businesses founded on research coming out of Imperial College London, University College London, Cambridge University and Oxford University.

Imperial has interests in over 30 such businesses, focused on therapeutics, medtech and medical devices, engineering, and information & communications technology. The group has a market capitalisation of £395m and net assets of £255m. The book value of 1.5x doesn’t look glaringly expensive given the potential for substantial uplifts in the value of the underlying holdings.

IP Group (LSE: IPO), founded in 2001, is similar to Imperial Innovations, but is rather larger, being a member of the FTSE 250, and having holdings in no fewer than 87 businesses. IP also draws on a much wider range of universities — all across the UK and as far afield as Princeton in the US — but, like Imperial, focuses on techie sectors: energy & renewables, healthcare, biotech, information & communications technology and chemicals & materials.

The group has a market capitalisation of £861m and net assets of £530m. The book value of 1.6x again doesn’t look extortionate.

More on Investing Articles

Female florist with Down's syndrome working in small business
Investing Articles

2 promising penny stocks to buy on the dip

As stock markets continue to correct, I am hunting for oversold penny stocks that I think could help turbocharge my…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

I wouldn’t buy Bitcoin today. FTSE value stocks look much better value to me

Now looks like a promising time to buy UK value stocks, while Bitcoin still looks far too risky for me.

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

The Rolls-Royce share price is below 85p. Here’s what I’m doing!

The Rolls-Royce share price has suffered this year. Trading for below 85p, this Fool decides whether this is an opportunity…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

4 dividend stocks to buy as inflation soars!

I'm hunting for the best dividend stock to invest in as global inflation soars. Here are several high-dividend-yield shares that…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

UK shares to buy now: 3 big fallers I’d snap up

Our writer thinks this trio of strong business performers could be attractive UK shares to buy now for his portfolio.

Read more »

Lady researching stocks
Investing Articles

Could a falling stock market help me get rich?

When the stock market falls, what does it mean for our writer's portfolio? Here's why it could be an opportunity.

Read more »

Hand holding pound notes
Investing Articles

Should I buy these two 12%-yielding dividend shares for my Stocks and Shares ISA?

Do these double-digit dividend yielders offer our author the right balance of risk and reward for his Stocks and Shares…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 reasons to buy Lloyds shares at 43p

Our writer outlines three factors that make him bullish on Lloyds shares, as well as one noteworthy risk facing the…

Read more »